Trademark Alertz ®
Search
Trademark
Owner
Trademark: Floratek 2236765
Word
Floratek
ID
2236765
Trademark Type
Word
Status
Protected: Registered/protected
Application Date
13 October 2021
Registration Date
13 October 2021
Renewal Date
13 October 2031
Owner(s)
Floratek Pharma SA
Service
Chrysiliou IP
Goods and Services:
Class 5
:
Pharmaceutical products
;
pharmaceutical drugs
;
medicinal preparations and substances
;
all aforementioned goods excluding herbicides
;
herbicides for agricultural use
;
fungicides
;
fungicides for agricultural use
;
fungicides for horticultural use
;
turf fungicides
;
biological insecticides
;
chemicals for forestry (insecticides)
;
insecticides
;
parasiticides
;
weedkillers
;
therapeutic preparations for the cardiovascular system
;
pharmaceutical and medicinal preparations and substances for the treatment of diabetes
;
pharmaceutical and medicinal preparations and substances for use in oncology
;
pharmaceutical and medicinal preparations, substances and compositions for the treatment and/or prevention of cancer
;
pharmaceutical and medicinal preparations and substances for the treatment of neurodegenerative disorders
;
pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders
;
pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders
;
pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis
;
pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases.
Class 42
:
Scientific research
;
pharmaceutical research
;
medicinal research
;
technical advice and product development for third parties in the field of pharmacy
;
research and development of pharmaceuticals and medicinal preparations and substances for third parties
;
research and development of pharmaceuticals and medicinal preparations and substances for the treatment of cancer
;
research and development of pharmaceuticals and medicinal preparations and substances for treating inflammation
;
research and development of pharmaceuticals and medicinal preparations and substances for the treatment of neurodegenerative disorders
;
research and development of pharmaceutical and medicinal preparations and substances for the treatment of metabolic disorders
;
research and development of pharmaceutical and medicinal preparations and substances for the treatment of musculoskeletal disorders
;
research and development of pharmaceutical and medicinal preparations and substances for the treatment of osteoarthritis
;
research and development of pharmaceutical and medicinal preparations and substances for the treatment of genetic disorders and rare diseases.